{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:53:28Z","timestamp":1791928408466,"version":"4.3.4"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jinhua Municipal Science and Technology Plan Project Social Development Major Projects","award":["2023-3-067 and 2026-3-066"],"award-info":[{"award-number":["2023-3-067 and 2026-3-066"]}]},{"name":"Jinhua Municipal Science and Technology Plan Project Social Development Major Projects","award":["2023-3-067 and 2026-3-066"],"award-info":[{"award-number":["2023-3-067 and 2026-3-066"]}]},{"name":"Jinhua Municipal Science and Technology Plan Project Social Development Major Projects","award":["2023-3-067 and 2026-3-066"],"award-info":[{"award-number":["2023-3-067 and 2026-3-066"]}]},{"name":"Jinhua Municipal Science and Technology Plan Project Social Development Major Projects","award":["2023-3-067 and 2026-3-066"],"award-info":[{"award-number":["2023-3-067 and 2026-3-066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"DOI":"10.1007\/s13679-026-00732-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:38:00Z","timestamp":1782700680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipid Metabolic Disorders: a Pivotal Driver in Type 2 Diabetes Mellitus Pathogenesis"],"prefix":"10.1007","volume":"15","author":[{"given":"Junqi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9063-7592","authenticated-orcid":false,"given":"Guigfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","unstructured":"Global regional,\u00a0and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.\u00a0","DOI":"10.1016\/S0140-6736(23)01301-6"},{"key":"732_CR2","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium. 2021. https:\/\/www.diabetesatlas.org\/"},{"issue":"9","key":"732_CR3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00125-024-06198-1","volume":"67","author":"M Byndloss","year":"2023","unstructured":"Byndloss M, Devkota S, Duca F, Niess JH, Nieuwdorp M, Orho-Melander M, et al. The gut microbiota and diabetes: research, translation, and clinical applications\u2009\u2212\u20092023 Diabetes, Diabetes Care, and Diabetologia Expert Forum. Diabetologia. 2023;67(9):1760\u201382. https:\/\/doi.org\/10.1007\/s00125-024-06198-1.","journal-title":"Diabetologia"},{"issue":"6","key":"732_CR4","first-page":"401","volume":"45","author":"K-T Kao","year":"2016","unstructured":"Kao K-T, Sabin MA. Type 2 diabetes mellitus in children and adolescents. Aust Fam Physician. 2016;45(6):401\u20136.","journal-title":"Aust Fam Physician"},{"key":"732_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00282-1","author":"SH Song","year":"2024","unstructured":"Song SH, Frier BM. Young adult-onset type 2 diabetes heralds a poor prognosis. Lancet Diabetes Endocrinol. 2024. https:\/\/doi.org\/10.1016\/S2213-8587(24)00282-1.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"732_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01951-9","volume":"9","author":"X Lu","year":"2024","unstructured":"Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, et al. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Signal Transduct Target Ther. 2024;9(1):262. https:\/\/doi.org\/10.1038\/s41392-024-01951-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"732_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02046-5","volume":"22","author":"H Yuge","year":"2023","unstructured":"Yuge H, Okada H, Hamaguchi M, Kurogi K, Murata H, Ito M, et al. Triglycerides\/HDL cholesterol ratio and type 2 diabetes incidence: Panasonic Cohort Study 10. Cardiovasc Diabetol. 2023;22(1):308. https:\/\/doi.org\/10.1186\/s12933-023-02046-5.","journal-title":"Cardiovasc Diabetol"},{"key":"732_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2020.101082","volume":"81","author":"G Desoye","year":"2020","unstructured":"Desoye G, Herrera E. Adipose tissue development and lipid metabolism in the human fetus: the 2020 perspective focusing on maternal diabetes and obesity. Prog Lipid Res. 2020;81:101082. https:\/\/doi.org\/10.1016\/j.plipres.2020.101082.","journal-title":"Prog Lipid Res"},{"issue":"3","key":"732_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2337\/dc22-1024","volume":"46","author":"TA Khan","year":"2023","unstructured":"Khan TA, Field D, Chen V, Ahmad S, Mejia SB, Kahleov\u00e1 H, et al. Combination of multiple low-risk lifestyle behaviors and incident type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care. 2023;46(3):643\u201356. https:\/\/doi.org\/10.2337\/dc22-1024.","journal-title":"Diabetes Care"},{"issue":"5","key":"732_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tem.2014.03.002","volume":"25","author":"P Arner","year":"2014","unstructured":"Arner P, Langin D. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab. 2014;25(5):255\u201362. https:\/\/doi.org\/10.1016\/j.tem.2014.03.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"732_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0014-5793(79)80005-8","volume":"102","author":"J Nikawa","year":"1979","unstructured":"Nikawa J, Tanabe T, Ogiwara H, Shiba T, Numa S. Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase. FEBS Lett. 1979;102(2):223\u20136.","journal-title":"FEBS Lett"},{"issue":"5","key":"732_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835. https:\/\/doi.org\/10.1097\/hep.0000000000000323.","journal-title":"Hepatology"},{"issue":"1","key":"732_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122(1):4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z.","journal-title":"Br J Cancer"},{"issue":"2","key":"732_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.476","volume":"5","author":"J Guo","year":"2024","unstructured":"Guo J, Chen S, Zhang Y, Liu J, Jiang L, Hu L, et al. Cholesterol metabolism: physiological regulation and diseases. MedComm (NY). 2024;5(2):e476. https:\/\/doi.org\/10.1002\/mco2.476.","journal-title":"MedComm (NY)"},{"key":"732_CR15","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnag014","author":"H Kim","year":"2026","unstructured":"Kim H, Kulkarni RN. Insulin\/IGF signaling in islet biology and its therapeutic implications. Endocr Rev. 2026. https:\/\/doi.org\/10.1210\/endrev\/bnag014.","journal-title":"Endocr Rev"},{"issue":"8","key":"732_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.tem.2017.05.002","volume":"28","author":"JR Jaldin-Fincati","year":"2017","unstructured":"Jaldin-Fincati JR, Pavarotti M, Frendo-Cumbo S, Bilan PJ, Klip A. Update on GLUT4 vesicle traffic: a cornerstone of insulin action. Trends Endocrinol Metab. 2017;28(8):597\u2013611. https:\/\/doi.org\/10.1016\/j.tem.2017.05.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"732_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrm3351","volume":"13","author":"D Leto","year":"2012","unstructured":"Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13(6):383\u201396. https:\/\/doi.org\/10.1038\/nrm3351.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"732_CR18","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/jme-17-0151","volume":"60","author":"J Peng","year":"2018","unstructured":"Peng J, He L. IRS posttranslational modifications in regulating insulin signaling. J Mol Endocrinol. 2018;60(1):R1\u2013r8. https:\/\/doi.org\/10.1530\/jme-17-0151.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"732_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13679-026-00685-9","volume":"15","author":"I Jeong","year":"2026","unstructured":"Jeong I, Kim OK. Pathophysiological roles of obesity-induced alterations in extracellular vesicles derived from adipose tissue and adipocytes. Curr Obes Rep. 2026;15(1):7. https:\/\/doi.org\/10.1007\/s13679-026-00685-9.","journal-title":"Curr Obes Rep"},{"issue":"2","key":"732_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/eje-14-1103","volume":"173","author":"LE Aguirre","year":"2015","unstructured":"Aguirre LE, Colleluori G, Fowler KE, Jan IZ, Villareal K, Qualls C, et al. High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass. Eur J Endocrinol. 2015;173(2):167\u201374. https:\/\/doi.org\/10.1530\/eje-14-1103.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"732_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00125-013-3139-y","volume":"57","author":"J Haase","year":"2014","unstructured":"Haase J, Weyer U, Immig K, Kl\u00f6ting N, Bl\u00fcher M, Eilers J, et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia. 2014;57(3):562\u201371. https:\/\/doi.org\/10.1007\/s00125-013-3139-y.","journal-title":"Diabetologia"},{"issue":"39","key":"732_CR22","doi-asserted-by":"publisher","first-page":"15888","DOI":"10.1073\/pnas.1205847109","volume":"109","author":"W Cai","year":"2012","unstructured":"Cai W, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1. Proc Natl Acad Sci U S A. 2012;109(39):15888\u201393. https:\/\/doi.org\/10.1073\/pnas.1205847109.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.lfs.2016.09.025","volume":"166","author":"L Ye","year":"2016","unstructured":"Ye L, Liang S, Guo C, Yu X, Zhao J, Zhang H, et al. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance. Life Sci. 2016;166:82\u201391. https:\/\/doi.org\/10.1016\/j.lfs.2016.09.025.","journal-title":"Life Sci"},{"issue":"24","key":"732_CR24","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1073\/pnas.1119038109","volume":"109","author":"A Arranz","year":"2012","unstructured":"Arranz A, Doxaki C, Vergadi E, Martinez de la Torre Y, Vaporidi K, Lagoudaki ED, et al. Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci USA. 2012;109(24):9517\u201322. https:\/\/doi.org\/10.1073\/pnas.1119038109.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"732_CR25","doi-asserted-by":"publisher","first-page":"20070","DOI":"10.1038\/s41598-020-76952-z","volume":"10","author":"C Blasetti Fantauzzi","year":"2020","unstructured":"Blasetti Fantauzzi C, Iacobini C, Menini S, Vitale M, Sorice GP, Mezza T, et al. Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis. Sci Rep. 2020;10(1):20070. https:\/\/doi.org\/10.1038\/s41598-020-76952-z.","journal-title":"Sci Rep"},{"issue":"6","key":"732_CR26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.cmet.2014.10.010","volume":"20","author":"SM Kim","year":"2014","unstructured":"Kim SM, Lun M, Wang M, Senyo SE, Guillermier C, Patwari P, et al. Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance. Cell Metabol. 2014;20(6):1049\u201358. https:\/\/doi.org\/10.1016\/j.cmet.2014.10.010.","journal-title":"Cell Metabol"},{"key":"732_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116116","volume":"222","author":"MJ Lee","year":"2024","unstructured":"Lee MJ, Kim J. The pathophysiology of visceral adipose tissues in cardiometabolic diseases. Biochem Pharmacol. 2024;222:116116. https:\/\/doi.org\/10.1016\/j.bcp.2024.116116.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"732_CR28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1152\/physrev.00034.2017","volume":"98","author":"A Hammarstedt","year":"2018","unstructured":"Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity. Physiol Rev. 2018;98(4):1911\u201341. https:\/\/doi.org\/10.1152\/physrev.00034.2017.","journal-title":"Physiol Rev"},{"key":"732_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-031-63657-8_4","volume":"1460","author":"A Engin","year":"2024","unstructured":"E A. Lipid Storage, Lipolysis, and Lipotoxicity in Obesity. Adv Exp Med Biol. 2024;1460:97\u2013129. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_4.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"732_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/CIRCRESAHA.125.325532","volume":"137","author":"KL Whytock","year":"2025","unstructured":"Whytock KL, Goodpaster BH. Unraveling skeletal muscle insulin resistance: molecular mechanisms and the restorative role of exercise. Circ Res. 2025;137(2):184\u2013204.","journal-title":"Circ Res"},{"issue":"1","key":"732_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2009.11.003","volume":"11","author":"KD Copps","year":"2010","unstructured":"Copps KD, Hancer NJ, Opare-Ado L, Qiu W, Walsh C, White MF. Irs1 serine 307 promotes insulin sensitivity in mice. Cell Metab. 2010;11(1):84\u201392. https:\/\/doi.org\/10.1016\/j.cmet.2009.11.003.","journal-title":"Cell Metab"},{"key":"732_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009191","author":"J Boucher","year":"2014","unstructured":"Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014. https:\/\/doi.org\/10.1101\/cshperspect.a009191.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"732_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","volume":"36","author":"C Koliaki","year":"2016","unstructured":"Koliaki C, Roden M. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus. Annu Rev Nutr. 2016;36:337\u201367. https:\/\/doi.org\/10.1146\/annurev-nutr-071715-050656.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"732_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/jci30400","volume":"117","author":"VT Samuel","year":"2007","unstructured":"Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, et al. Inhibition of protein kinase C\u03b5 prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest. 2007;117(3):739\u201345. https:\/\/doi.org\/10.1172\/jci30400.","journal-title":"J Clin Invest"},{"issue":"26","key":"732_CR35","doi-asserted-by":"publisher","first-page":"9597","DOI":"10.1073\/pnas.1409229111","volume":"111","author":"J Szendroedi","year":"2014","unstructured":"Szendroedi J, Yoshimura T, Phielix E, Koliaki C, Marcucci M, Zhang D, et al. Role of diacylglycerol activation of PKC\u03b8 in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A. 2014;111(26):9597\u2013602. https:\/\/doi.org\/10.1073\/pnas.1409229111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"732_CR36","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s00125-016-3865-z","volume":"59","author":"A Gemmink","year":"2016","unstructured":"Gemmink A, Bosma M, Kuijpers HJ, Hoeks J, Schaart G, van Zandvoort MA, et al. Decoration of intramyocellular lipid droplets with PLIN5 modulates fasting-induced insulin resistance and lipotoxicity in humans. Diabetologia. 2016;59(5):1040\u20138. https:\/\/doi.org\/10.1007\/s00125-016-3865-z.","journal-title":"Diabetologia"},{"issue":"19","key":"732_CR37","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/rcm.7941","volume":"31","author":"LA Gethings","year":"2017","unstructured":"Gethings LA, Richardson K, Wildgoose J, Lennon S, Jarvis S, Bevan CL, et al. Lipid profiling of complex biological mixtures by liquid chromatography\/mass spectrometry using a novel scanning quadrupole data-independent acquisition strategy. Rapid Commun mass spectrometry: RCM. 2017;31(19):1599\u2013606. https:\/\/doi.org\/10.1002\/rcm.7941.","journal-title":"Rapid Commun mass spectrometry: RCM"},{"issue":"1","key":"732_CR38","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/jme-18-0023","volume":"62","author":"LK Metcalfe","year":"2019","unstructured":"Metcalfe LK, Smith GC, Turner N. Defining lipid mediators of insulin resistance: controversies and challenges. J Mol Endocrinol. 2019;62(1):R65\u2013r82. https:\/\/doi.org\/10.1530\/jme-18-0023.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"732_CR39","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1017\/S0954422424000179","volume":"38","author":"D Sergi","year":"2025","unstructured":"Sergi D, Zauli E, Celeghini C, Previati M, Zauli G. Ceramides as the molecular link between impaired lipid metabolism, saturated fatty acid intake and insulin resistance: are all saturated fatty acids to be blamed for ceramide-mediated lipotoxicity? Nutr Res Rev. 2025;38(1):256\u201366. https:\/\/doi.org\/10.1017\/S0954422424000179.","journal-title":"Nutr Res Rev"},{"key":"732_CR40","doi-asserted-by":"publisher","first-page":"109959","DOI":"10.1016\/j.cellsig.2021.109959","volume":"82","author":"D Wigger","year":"2021","unstructured":"Wigger D, Schumacher F, Schneider-Schaulies S, Kleuser B. Sphingosine 1-phosphate metabolism and insulin signaling. Cell Signal. 2021;82:109959. https:\/\/doi.org\/10.1016\/j.cellsig.2021.109959.","journal-title":"Cell Signal"},{"issue":"1","key":"732_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/jci88880","volume":"127","author":"H Wu","year":"2017","unstructured":"Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43\u201354. https:\/\/doi.org\/10.1172\/jci88880.","journal-title":"J Clin Invest"},{"issue":"1","key":"732_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/db09-0988","volume":"59","author":"PM Coen","year":"2010","unstructured":"Coen PM, Dub\u00e9 JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, et al. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes. 2010;59(1):80\u20138. https:\/\/doi.org\/10.2337\/db09-0988.","journal-title":"Diabetes"},{"issue":"7785","key":"732_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1797-8.","journal-title":"Nature"},{"issue":"1","key":"732_CR44","doi-asserted-by":"publisher","first-page":"e70185","DOI":"10.1002\/ueg2.70185","volume":"14","author":"M Vujasinovic","year":"2026","unstructured":"Vujasinovic M, Demir IE, Marchegiani G, Hegyi P, Archibugi L, Valente R, et al. International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG. United Eur Gastroenterol J. 2026;14(1):e70185. https:\/\/doi.org\/10.1002\/ueg2.70185.","journal-title":"United Eur Gastroenterol J"},{"issue":"15","key":"732_CR45","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3748\/wjg.15.1869","volume":"15","author":"JS Lee","year":"2009","unstructured":"Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol. 2009;15(15):1869\u201375. https:\/\/doi.org\/10.3748\/wjg.15.1869.","journal-title":"World J Gastroenterol"},{"key":"732_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2026.113149","volume":"236","author":"S Ahmad","year":"2026","unstructured":"Ahmad S, Sul HH, Danpanichkul P, Souza M. High prevalence of fatty pancreas disease in type 2 diabetes mellitus: a meta-analysis. Diabetes Res Clin Pract. 2026;236:113149. https:\/\/doi.org\/10.1016\/j.diabres.2026.113149.","journal-title":"Diabetes Res Clin Pract"},{"key":"732_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040880","author":"KW Chung","year":"2021","unstructured":"Chung KW. Advances in understanding of the role of lipid metabolism in aging. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10040880.","journal-title":"Cells"},{"issue":"6696","key":"732_CR48","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/29795","volume":"394","author":"GM Lord","year":"1998","unstructured":"Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897\u2013901. https:\/\/doi.org\/10.1038\/29795.","journal-title":"Nature"},{"issue":"11","key":"732_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41574-025-01149-1","volume":"21","author":"R Fern\u00e1ndez-Verdejo","year":"2025","unstructured":"Fern\u00e1ndez-Verdejo R, Ravussin E, Galgani JE. Body weight regulation models in humans: insights for testing their validity. Nat Rev Endocrinol. 2025;21(11):703\u201317. https:\/\/doi.org\/10.1038\/s41574-025-01149-1.","journal-title":"Nat Rev Endocrinol"},{"issue":"17","key":"732_CR50","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.neuron.2025.07.016","volume":"113","author":"JS Chadwick","year":"2025","unstructured":"Chadwick JS, Decourt C, M\u00fcller F, Maldonado-Lasuncion I, Serger E, Kong G, et al. Dietary-dependent sensitization of neuronal leptin signaling promotes neural repair after injury via cAMP and gene transcription. Neuron. 2025;113(17):2839\u20132855.e2838. https:\/\/doi.org\/10.1016\/j.neuron.2025.07.016.","journal-title":"Neuron"},{"key":"732_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2017.168","author":"WW Pan","year":"2018","unstructured":"Pan WW, Myers MG. Leptin and the maintenance of elevated body weight. Nat Rev Neurosci. 2018. https:\/\/doi.org\/10.1038\/nrn.2017.168.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"732_CR52","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/aps.2018.40","volume":"39","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39(7):1176\u201388. https:\/\/doi.org\/10.1038\/aps.2018.40.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"732_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/circresaha.120.314458","volume":"128","author":"S Zhao","year":"2021","unstructured":"Zhao S, Kusminski CM, Scherer PE. Adiponectin, leptin and cardiovascular disorders. Circ Res. 2021;128(1):136\u201349. https:\/\/doi.org\/10.1161\/circresaha.120.314458.","journal-title":"Circ Res"},{"key":"732_CR54","doi-asserted-by":"publisher","first-page":"154959","DOI":"10.1016\/j.metabol.2021.154959","volume":"128","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang Y, Liu Z, He L. Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function. Metabolism. 2022;128:154959. https:\/\/doi.org\/10.1016\/j.metabol.2021.154959.","journal-title":"Metabolism"},{"issue":"1","key":"732_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12035-025-05383-6","volume":"63","author":"H Gong","year":"2025","unstructured":"Gong H, Liu Y, Xia L, Niu B, Kong J, Wang B, et al. Adiponectin Signaling Ameliorates Cognitive Dysfunction in Type 2 Diabetic Mice by Activating the Hippocampal AdipoR2-PPAR\u03b1\/CREB Pathway. Mol Neurobiol. 2025;63(1):68. https:\/\/doi.org\/10.1007\/s12035-025-05383-6.","journal-title":"Mol Neurobiol"},{"issue":"19","key":"732_CR56","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1073\/pnas.96.19.10857","volume":"96","author":"Y Tanaka","year":"1999","unstructured":"Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A. 1999;96(19):10857\u201362. https:\/\/doi.org\/10.1073\/pnas.96.19.10857.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"732_CR57","doi-asserted-by":"publisher","first-page":"C420","DOI":"10.1152\/ajpcell.00141.2019","volume":"317","author":"P Newsholme","year":"2019","unstructured":"Newsholme P, Keane KN, Carlessi R, Cruzat V. Oxidative stress pathways in pancreatic \u03b2-cells and insulin-sensitive cells and tissues: importance to cell metabolism, function, and dysfunction. Am J Physiol Cell Physiol. 2019;317(3):C420\u2013c433. https:\/\/doi.org\/10.1152\/ajpcell.00141.2019.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"732_CR58","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11892-010-0122-6","volume":"10","author":"K Cusi","year":"2010","unstructured":"Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep. 2010;10(4):306\u201315. https:\/\/doi.org\/10.1007\/s11892-010-0122-6.","journal-title":"Curr Diab Rep"},{"issue":"7","key":"732_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/cm9.0000000000003034","volume":"137","author":"D Cui","year":"2024","unstructured":"Cui D, Feng X, Lei S, Zhang H, Hu W, Yang S, et al. Pancreatic \u03b2-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes. Chin Med J. 2024;137(7):791\u2013805. https:\/\/doi.org\/10.1097\/cm9.0000000000003034.","journal-title":"Chin Med J"},{"issue":"3","key":"732_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/er.2007-0023","volume":"29","author":"V Poitout","year":"2008","unstructured":"Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev. 2008;29(3):351\u201366. https:\/\/doi.org\/10.1210\/er.2007-0023.","journal-title":"Endocr Rev"},{"issue":"4","key":"732_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1463-1326.2008.00952.x","volume":"10","author":"G Leibowitz","year":"2008","unstructured":"Leibowitz G, Cerasi E, Ketzinel-Gilad M. The role of mTOR in the adaptation and failure of beta-cells in type 2 diabetes. Diabetes Obes Metab. 2008;10(4):157\u201369. https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00952.x.","journal-title":"Diabetes Obes Metab"},{"key":"732_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00114","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 2018;9:114. https:\/\/doi.org\/10.3389\/fphys.2018.00114.","journal-title":"Front Physiol"},{"issue":"5","key":"732_CR63","doi-asserted-by":"publisher","first-page":"E912","DOI":"10.1152\/ajpendo.00461.2017","volume":"315","author":"M Sokolova","year":"2018","unstructured":"Sokolova M, Sahraoui A, H\u00f8yem M, \u00d8gaard J, Lien E, Aukrust P, et al. NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction. Am J Physiol Endocrinol Metab. 2018;315(5):E912\u2013e923. https:\/\/doi.org\/10.1152\/ajpendo.00461.2017.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"732_CR64","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00125-020-05192-7","volume":"63","author":"J Vasiljevi\u0107","year":"2020","unstructured":"Vasiljevi\u0107 J, Torkko JM, Knoch KP, Solimena M. The making of insulin in health and disease. Diabetologia. 2020;63(10):1981\u20139. https:\/\/doi.org\/10.1007\/s00125-020-05192-7.","journal-title":"Diabetologia"},{"key":"732_CR65","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-52479-5_12","volume":"974","author":"PC Guest","year":"2017","unstructured":"Guest PC. 2D Gel Electrophoresis of Insulin Secretory Granule Proteins from Biosynthetically Labelled Pancreatic Islets. Adv Exp Med Biol. 2017;974:167\u201374. https:\/\/doi.org\/10.1007\/978-3-319-52479-5_12.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"732_CR66","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00125-012-2604-3","volume":"55","author":"I Marhfour","year":"2012","unstructured":"Marhfour I, Lopez XM, Lefkaditis D, Salmon I, Allagnat F, Richardson SJ, et al. Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia. 2012;55(9):2417\u201320. https:\/\/doi.org\/10.1007\/s00125-012-2604-3.","journal-title":"Diabetologia"},{"issue":"4","key":"732_CR67","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s00125-006-0590-z","volume":"50","author":"DR Laybutt","year":"2007","unstructured":"Laybutt DR, Preston AM, Akerfeldt MC, Kench JG, Busch AK, Biankin AV, et al. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia. 2007;50(4):752\u201363. https:\/\/doi.org\/10.1007\/s00125-006-0590-z.","journal-title":"Diabetologia"},{"issue":"23","key":"732_CR68","doi-asserted-by":"publisher","first-page":"16290","DOI":"10.1074\/jbc.M114.562355","volume":"289","author":"H Guo","year":"2014","unstructured":"Guo H, Xiong Y, Witkowski P, Cui J, Wang LJ, Sun J, et al. Inefficient translocation of preproinsulin contributes to pancreatic \u03b2 cell failure and late-onset diabetes. J Biol Chem. 2014;289(23):16290\u2013302. https:\/\/doi.org\/10.1074\/jbc.M114.562355.","journal-title":"J Biol Chem"},{"issue":"8","key":"732_CR69","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41574-021-00510-4","volume":"17","author":"J Yong","year":"2021","unstructured":"Yong J, Johnson JD, Arvan P, Han J, Kaufman RJ. Therapeutic opportunities for pancreatic \u03b2-cell ER stress in diabetes mellitus. Nat Rev Endocrinol. 2021;17(8):455\u201367. https:\/\/doi.org\/10.1038\/s41574-021-00510-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"732_CR70","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jmb.2019.09.016","volume":"432","author":"M Lytrivi","year":"2020","unstructured":"Lytrivi M, Castell AL, Poitout V, Cnop M. Recent insights into mechanisms of \u03b2-cell lipo- and glucolipotoxicity in type 2 diabetes. J Mol Biol. 2020;432(5):1514\u201334. https:\/\/doi.org\/10.1016\/j.jmb.2019.09.016.","journal-title":"J Mol Biol"},{"issue":"2","key":"732_CR71","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.celrep.2023.112066","volume":"42","author":"V Kovaleva","year":"2023","unstructured":"Kovaleva V, Yu LY, Ivanova L, Shpironok O, Nam J, Eesmaa A, et al. MANF regulates neuronal survival and UPR through its ER-located receptor IRE1\u03b1. Cell Rep. 2023;42(2):112066. https:\/\/doi.org\/10.1016\/j.celrep.2023.112066.","journal-title":"Cell Rep"},{"issue":"2","key":"732_CR72","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1096\/fj.15-275883","volume":"30","author":"D Eletto","year":"2016","unstructured":"Eletto D, Eletto D, Boyle S, Argon Y. PDIA6 regulates insulin secretion by selectively inhibiting the RIDD activity of IRE1. FASEB J. 2016;30(2):653\u201365. https:\/\/doi.org\/10.1096\/fj.15-275883.","journal-title":"FASEB J"},{"issue":"7","key":"732_CR73","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41574-020-0355-7","volume":"16","author":"DL Eizirik","year":"2020","unstructured":"Eizirik DL, Pasquali L, Cnop M. Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020;16(7):349\u201362. https:\/\/doi.org\/10.1038\/s41574-020-0355-7.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"732_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114358","volume":"43","author":"F Xu","year":"2024","unstructured":"Xu F, Wang L. Deciphering ER stress-unfolded protein response relationship by visualizing unfolded proteins in the ER. Cell Rep. 2024;43(6):114358. https:\/\/doi.org\/10.1016\/j.celrep.2024.114358.","journal-title":"Cell Rep"},{"issue":"1","key":"732_CR75","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41467-023-36680-0","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Han S, Liu C, Zheng Y, Li H, Gao F, et al. THADA inhibition in mice protects against type 2 diabetes mellitus by improving pancreatic \u03b2-cell function and preserving \u03b2-cell mass. Nat Commun. 2023;14(1):1020. https:\/\/doi.org\/10.1038\/s41467-023-36680-0.","journal-title":"Nat Commun"},{"issue":"1","key":"732_CR76","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12933-024-02505-7","volume":"23","author":"L Berkowitz","year":"2024","unstructured":"Berkowitz L, Razquin C, Salazar C, Biancardi F, Estruch R, Ros E, et al. Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies. Cardiovasc Diabetol. 2024;23(1):446. https:\/\/doi.org\/10.1186\/s12933-024-02505-7.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"732_CR77","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jn\/136.4.873","volume":"136","author":"V Poitout","year":"2006","unstructured":"Poitout V, Hagman D, Stein R, Artner I, Robertson RP, Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr. 2006;136(4):873\u20136. https:\/\/doi.org\/10.1093\/jn\/136.4.873.","journal-title":"J Nutr"},{"issue":"21","key":"732_CR78","doi-asserted-by":"publisher","first-page":"20804","DOI":"10.1074\/jbc.M410869200","volume":"280","author":"H Kashkar","year":"2005","unstructured":"Kashkar H, Wiegmann K, Yazdanpanah B, Haubert D, Kr\u00f6nke M. Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane. J Biol Chem. 2005;280(21):20804\u201313. https:\/\/doi.org\/10.1074\/jbc.M410869200.","journal-title":"J Biol Chem"},{"issue":"6","key":"732_CR79","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.2337\/diabetes.54.6.1838","volume":"54","author":"JM Cacicedo","year":"2005","unstructured":"Cacicedo JM, Benjachareowong S, Chou E, Ruderman NB, Ido Y. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes. 2005;54(6):1838\u201345. https:\/\/doi.org\/10.2337\/diabetes.54.6.1838.","journal-title":"Diabetes"},{"issue":"17","key":"732_CR80","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.cir.0000035650.05921.50","volume":"106","author":"H Li","year":"2002","unstructured":"Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, et al. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation. 2002;106(17):2250\u20136. https:\/\/doi.org\/10.1161\/01.cir.0000035650.05921.50.","journal-title":"Circulation"},{"issue":"11","key":"732_CR81","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1074\/jbc.M706115200","volume":"283","author":"LJ Siskind","year":"2008","unstructured":"Siskind LJ, Feinstein L, Yu T, Davis JS, Jones D, Choi J, et al. Anti-apoptotic Bcl-2 Family Proteins Disassemble Ceramide Channels. J Biol Chem. 2008;283(11):6622\u201330. https:\/\/doi.org\/10.1074\/jbc.M706115200.","journal-title":"J Biol Chem"},{"issue":"12","key":"732_CR82","doi-asserted-by":"publisher","first-page":"e1003451","DOI":"10.1371\/journal.pmed.1003451","volume":"17","author":"H Yun","year":"2020","unstructured":"Yun H, Sun L, Wu Q, Zong G, Qi Q, Li H, et al. Associations among circulating sphingolipids, \u03b2-cell function, and risk of developing type 2 diabetes: A population-based cohort study in China. PLoS Med. 2020;17(12):e1003451. https:\/\/doi.org\/10.1371\/journal.pmed.1003451.","journal-title":"PLoS Med"},{"issue":"1","key":"732_CR83","doi-asserted-by":"publisher","first-page":"2111951","DOI":"10.1080\/19490976.2022.2111951","volume":"14","author":"TPM Scheithauer","year":"2022","unstructured":"Scheithauer TPM, Herrema H, Yu H, Bakker GJ, Winkelmeijer M, Soukhatcheva G, et al. Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction. Gut Microbes. 2022;14(1):2111951. https:\/\/doi.org\/10.1080\/19490976.2022.2111951.","journal-title":"Gut Microbes"},{"issue":"6","key":"732_CR84","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00125-017-4278-3","volume":"60","author":"L Brunkwall","year":"2017","unstructured":"Brunkwall L, Orho-Melander M. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities. Diabetologia. 2017;60(6):943\u201351. https:\/\/doi.org\/10.1007\/s00125-017-4278-3.","journal-title":"Diabetologia"},{"issue":"2","key":"732_CR85","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s13679-019-00334-4","volume":"8","author":"MG Browning","year":"2019","unstructured":"Browning MG, Pessoa BM, Khoraki J, Campos GM. Changes in bile acid metabolism, transport, and signaling as central drivers for metabolic improvements after bariatric surgery. Curr Obes Rep. 2019;8(2):175\u201384. https:\/\/doi.org\/10.1007\/s13679-019-00334-4.","journal-title":"Curr Obes Rep"},{"issue":"8049","key":"732_CR86","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41586-024-08379-9","volume":"638","author":"TH Won","year":"2025","unstructured":"Won TH, Arifuzzaman M, Parkhurst CN, Miranda IC, Zhang B, Hu E, et al. Host metabolism balances microbial regulation of bile acid signalling. Nature. 2025;638(8049):216\u201324. https:\/\/doi.org\/10.1038\/s41586-024-08379-9.","journal-title":"Nature"},{"issue":"2","key":"732_CR87","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328. https:\/\/doi.org\/10.1038\/nrgastro.2017.119.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"732_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1084\/jem.20171965","volume":"215","author":"H Shapiro","year":"2018","unstructured":"Shapiro H, Kolodziejczyk AA, Halstuch D, Elinav E. Bile acids in glucose metabolism in health and disease. J Exp Med. 2018;215(2):383\u201396. https:\/\/doi.org\/10.1084\/jem.20171965.","journal-title":"J Exp Med"},{"issue":"7499","key":"732_CR89","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature13135","volume":"509","author":"KK Ryan","year":"2014","unstructured":"Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183\u20138. https:\/\/doi.org\/10.1038\/nature13135.","journal-title":"Nature"},{"issue":"2","key":"732_CR90","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin SI, Wahlstr\u00f6m A, Felin J, J\u00e4ntti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabol. 2013;17(2):225\u201335. https:\/\/doi.org\/10.1016\/j.cmet.2013.01.003.","journal-title":"Cell Metabol"},{"issue":"2","key":"732_CR91","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.3760","volume":"21","author":"S Fang","year":"2015","unstructured":"Fang S, Suh JM, Reilly SM, Yu E, Osborn O, Lackey D, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med. 2015;21(2):159\u201365. https:\/\/doi.org\/10.1038\/nm.3760.","journal-title":"Nat Med"},{"issue":"7","key":"732_CR92","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/db08-1637","volume":"58","author":"Z Gao","year":"2009","unstructured":"Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509\u201317. https:\/\/doi.org\/10.2337\/db08-1637.","journal-title":"Diabetes"},{"issue":"20","key":"732_CR93","doi-asserted-by":"publisher","first-page":"e2411086","DOI":"10.1002\/advs.202411086","volume":"12","author":"B Chen","year":"2025","unstructured":"Chen B, Guan L, Wu C, Gong Y, Wu L, Zhang M, et al. Gut Microbiota-Butyrate-PPAR\u03b3 Axis Modulates Adipose Regulatory T Cell Population. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2025;12(20):e2411086. https:\/\/doi.org\/10.1002\/advs.202411086.","journal-title":"Adv Sci (Weinheim Baden-Wurttemberg Germany)"},{"issue":"11","key":"732_CR94","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","volume":"50","author":"PD Cani","year":"2007","unstructured":"Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374\u201383. https:\/\/doi.org\/10.1007\/s00125-007-0791-0.","journal-title":"Diabetologia"},{"key":"732_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/biom15040469","author":"E M\u00fcnte","year":"2025","unstructured":"M\u00fcnte E, Hartmann P. The role of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and other metabolic diseases. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15040469.","journal-title":"Biomolecules"},{"issue":"11","key":"732_CR96","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.tibs.2024.09.004","volume":"49","author":"W Chen","year":"2024","unstructured":"Chen W, Johansen VBI, Legido-Quigley C. Bridging brain insulin resistance to Alzheimer\u2019s pathogenesis. Trends Biochem Sci. 2024;49(11):939\u201341. https:\/\/doi.org\/10.1016\/j.tibs.2024.09.004.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"732_CR97","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.bbadis.2019.02.021","volume":"1865","author":"FA Cimini","year":"2019","unstructured":"Cimini FA, Arena A, Barchetta I, Tramutola A, Ceccarelli V, Lanzillotta C, et al. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2019;1865(6):1490\u2013501. https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.021.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"48","key":"732_CR98","doi-asserted-by":"publisher","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","volume":"291","author":"TD Hinds Jr","year":"2016","unstructured":"Hinds TD Jr., Burns KA, Hosick PA, McBeth L, Nestor-Kalinoski A, Drummond HA, et al. Biliverdin Reductase A Attenuates Hepatic Steatosis by Inhibition of Glycogen Synthase Kinase (GSK) 3\u03b2 Phosphorylation of Serine 73 of Peroxisome Proliferator-activated Receptor (PPAR) \u03b1. J Biol Chem. 2016;291(48):25179\u201391. https:\/\/doi.org\/10.1074\/jbc.M116.731703.","journal-title":"J Biol Chem"},{"issue":"11","key":"732_CR99","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70291","volume":"169","author":"MZ Kaya","year":"2025","unstructured":"Kaya MZ, Stranahan AM. Whispering through the barrier: signaling interfaces for peripheral regulation of brain function in obesity. J Neurochem. 2025;169(11):e70291. https:\/\/doi.org\/10.1111\/jnc.70291.","journal-title":"J Neurochem"},{"issue":"37","key":"732_CR100","doi-asserted-by":"publisher","first-page":"32324","DOI":"10.1074\/jbc.M111.254417","volume":"286","author":"Q Meng","year":"2011","unstructured":"Meng Q, Cai D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)\/NF-kappaB pathway. J Biol Chem. 2011;286(37):32324\u201332. https:\/\/doi.org\/10.1074\/jbc.M111.254417.","journal-title":"J Biol Chem"},{"issue":"2","key":"732_CR101","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cmet.2011.06.008","volume":"14","author":"S Kaushik","year":"2011","unstructured":"Kaushik S, Rodriguez-Navarro JA, Arias E, Kiffin R, Sahu S, Schwartz GJ, et al. Autophagy in hypothalamic AgRP neurons regulates food intake and energy balance. Cell Metab. 2011;14(2):173\u201383. https:\/\/doi.org\/10.1016\/j.cmet.2011.06.008.","journal-title":"Cell Metab"},{"issue":"1","key":"732_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03104-9","volume":"21","author":"Z Feng","year":"2024","unstructured":"Feng Z, Fang C, Ma Y, Chang J. Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms. J Neuroinflammation. 2024;21(1):110. https:\/\/doi.org\/10.1186\/s12974-024-03104-9.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"732_CR103","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s42255-024-01079-8","volume":"6","author":"O Le Thuc","year":"2024","unstructured":"Le Thuc O, Garc\u00eda-C\u00e1ceres C. Obesity-induced inflammation: connecting the periphery to the brain. Nat Metab. 2024;6(7):1237\u201352. https:\/\/doi.org\/10.1038\/s42255-024-01079-8.","journal-title":"Nat Metab"},{"key":"732_CR104","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2026.4106","author":"RF Kushner","year":"2026","unstructured":"Kushner RF, Chao AM, Wadden TA. Lifestyle modification and incretin-based therapy for obesity. JAMA. 2026. https:\/\/doi.org\/10.1001\/jama.2026.4106.","journal-title":"JAMA"},{"issue":"11","key":"732_CR105","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","volume":"3","author":"Long-term effects of lifestyle intervention or metformin on diabetes","year":"2015","unstructured":"Long-term effects of lifestyle intervention or metformin on diabetes. development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866\u201375. https:\/\/doi.org\/10.1016\/S2213-8587(15)00291-0.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"732_CR106","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.2337\/dc06-0560","volume":"29","author":"RF Hamman","year":"2006","unstructured":"Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102\u20137. https:\/\/doi.org\/10.2337\/dc06-0560.","journal-title":"Diabetes Care"},{"issue":"5","key":"732_CR107","doi-asserted-by":"publisher","first-page":"e2613102","DOI":"10.1001\/jamanetworkopen.2026.13102","volume":"9","author":"T Xia","year":"2026","unstructured":"Xia T, Haslam DE, Eliassen AH, Manson JE, Sun Q, Willett WC, et al. Optimal Dietary Patterns for Lower Weight Gain and Risk of Obesity Surrounding Menopause. JAMA Netw open. 2026;9(5):e2613102. https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.13102.","journal-title":"JAMA Netw open"},{"issue":"3","key":"732_CR108","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s43587-026-01091-5","volume":"6","author":"T Schmauck-Medina","year":"2026","unstructured":"Schmauck-Medina T, Lautrup S, Di Francesco A, Mitchell SJ, Clemmensen C, Partridge L, et al. Dietary restriction in aging and longevity. Nat aging. 2026;6(3):485\u2013505. https:\/\/doi.org\/10.1038\/s43587-026-01091-5.","journal-title":"Nat aging"},{"issue":"4","key":"732_CR109","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.molcel.2019.12.003","volume":"77","author":"CP Najt","year":"2020","unstructured":"Najt CP, Khan SA, Heden TD, Witthuhn BA, Perez M, Heier JL, et al. Lipid Droplet-Derived Monounsaturated Fatty Acids Traffic via PLIN5 to Allosterically Activate SIRT1. Mol Cell. 2020;77(4):810\u2013e824818. https:\/\/doi.org\/10.1016\/j.molcel.2019.12.003.","journal-title":"Mol Cell"},{"issue":"1","key":"732_CR110","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev-nutr-121624-114918","volume":"45","author":"SQ Kim","year":"2025","unstructured":"Kim SQ, Spann RA, Hill CM, Berryman CE, Berthoud HR, McDougal DH, et al. Protein-Restricted Diets and Their Impact on Metabolic Health and Aging. Annu Rev Nutr. 2025;45(1):269\u201397. https:\/\/doi.org\/10.1146\/annurev-nutr-121624-114918.","journal-title":"Annu Rev Nutr"},{"key":"732_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/med.70063","author":"H Wang","year":"2026","unstructured":"Wang H, Jin Z, Di S, Alizadeh H. Exercise-induced exerkines: multi-nodal suppression of the NLRP3 inflammasome and translational potential. Med Res Rev. 2026. https:\/\/doi.org\/10.1002\/med.70063.","journal-title":"Med Res Rev"},{"issue":"11","key":"732_CR112","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/sms.13240","volume":"28","author":"E C\u00e8","year":"2018","unstructured":"C\u00e8 E, Longo S, Paleari E, Riboli A, Limonta E, Rampichini S, et al. Evidence of balance training-induced improvement in soccer-specific skills in U11 soccer players. Scand J Med Sci Sports. 2018;28(11):2443\u201356. https:\/\/doi.org\/10.1111\/sms.13240.","journal-title":"Scand J Med Sci Sports"},{"key":"732_CR113","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2025-111474","author":"V Mallmann Schneider","year":"2026","unstructured":"Mallmann Schneider V, Klarmann Ziegelmann PP, Muniz Pereira DP, Ferrari R. Effects of different exercise training modalities on 24-hour ambulatory blood pressure in adults with hypertension: a network meta-analysis of randomised controlled trials. Br J Sports Med. 2026. https:\/\/doi.org\/10.1136\/bjsports-2025-111474.","journal-title":"Br J Sports Med"},{"issue":"3","key":"732_CR114","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2337\/dc25-2095","volume":"49","author":"Q Feng","year":"2026","unstructured":"Feng Q, Albalak G, Ao L, Xiao Q, Wang H, van der Velde J, et al. Associations of moderate-to-vigorous physical activity timing with type 2 diabetes incidence in UK Biobank and prevalent glycemic measures in NHANES. Diabetes Care. 2026;49(3):444\u20139. https:\/\/doi.org\/10.2337\/dc25-2095.","journal-title":"Diabetes Care"},{"issue":"5","key":"732_CR115","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1016\/j.apsb.2026.01.035","volume":"16","author":"M Abbasi","year":"2026","unstructured":"Abbasi M, Sun K, Huggins KW, Heath B, DeLoit H, McGinness L, et al. Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes. Acta Pharm Sin B. 2026;16(5):2682\u2013710. https:\/\/doi.org\/10.1016\/j.apsb.2026.01.035.","journal-title":"Acta Pharm Sin B"},{"key":"732_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-026-01258-5","author":"A Ceriello","year":"2026","unstructured":"Ceriello A, Prattichizzo F, Mastan Sheik Abdullah AR, La Grotta R, Berra CC, McGowan B, et al. Causes and consequences of discontinuation of GLP1RAs or tirzepatide. Nat Rev Endocrinol. 2026. https:\/\/doi.org\/10.1038\/s41574-026-01258-5.","journal-title":"Nat Rev Endocrinol"},{"key":"732_CR117","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1650729","volume":"16","author":"S Niu","year":"2025","unstructured":"Niu S, Chen S, Wu D, Wang C, Xu J, Yin J, et al. Multi-omics analysis of hepatic outcomes in T2DM-MAFLD patients treated with semaglutide: a single-centre, longitudinal, data-driven study. Front Endocrinol. 2025;16:1650729. https:\/\/doi.org\/10.3389\/fendo.2025.1650729.","journal-title":"Front Endocrinol"},{"key":"732_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2026.101464","volume":"109","author":"GK Bhatti","year":"2026","unstructured":"Bhatti GK, Ahmed I, Sehrawat A, Sharma PK, Kandimalla R, Kaura KS, et al. Dual-targeting strategies for cancer and diabetes: converging pharmacological pathways and repurposed therapies. Mol Aspects Med. 2026;109:101464. https:\/\/doi.org\/10.1016\/j.mam.2026.101464.","journal-title":"Mol Aspects Med"},{"issue":"12","key":"732_CR119","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1136\/gutjnl-2024-332481","volume":"73","author":"X Mao","year":"2024","unstructured":"Mao X, Zhang X, Kam L, Chien N, Lai R, Cheung KS, et al. Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease. Gut. 2024;73(12):2054\u201361. https:\/\/doi.org\/10.1136\/gutjnl-2024-332481.","journal-title":"Gut"},{"key":"732_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-8-16","volume":"8","author":"F Forcheron","year":"2009","unstructured":"Forcheron F, Basset A, Abdallah P, Del Carmine P, Gadot N, Beylot M. Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model\u2013the Zucker diabetic rat. Cardiovasc Diabetol. 2009;8:16. https:\/\/doi.org\/10.1186\/1475-2840-8-16.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"732_CR121","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","volume":"75","author":"R Marfella","year":"2020","unstructured":"Marfella R, Amarelli C, Cacciatore F, Balestrieri ML, Mansueto G, D\u2019Onofrio N, et al. Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients. J Am Coll Cardiol. 2020;75(11):1249\u201362. https:\/\/doi.org\/10.1016\/j.jacc.2020.01.018.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"732_CR122","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12974-024-03173-w","volume":"21","author":"A Pearson","year":"2024","unstructured":"Pearson A, Koprivica M, Eisenbaum M, Ortiz C, Browning M, Vincennie T, et al. PPAR\u03b3 activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI. J Neuroinflamm. 2024;21(1):194. https:\/\/doi.org\/10.1186\/s12974-024-03173-w.","journal-title":"J Neuroinflamm"},{"issue":"11","key":"732_CR123","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1463-1326.2008.00854.x","volume":"10","author":"V Hulstr\u00f8m","year":"2008","unstructured":"Hulstr\u00f8m V, H\u00f8jlund K, Vinten J, Beck-Nielsen H, Levin K. Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives. Diabetes Obes Metab. 2008;10(11):1019\u201328. https:\/\/doi.org\/10.1111\/j.1463-1326.2008.00854.x.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"732_CR124","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/dom.70257","volume":"28","author":"DH Seo","year":"2026","unstructured":"Seo DH, Min KW, Sohn HS, Kim SY, Jeong IK, Park CY, et al. Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial. Diabetes Obes Metab. 2026;28(1):728\u201340. https:\/\/doi.org\/10.1111\/dom.70257.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"732_CR125","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/19490976.2018.1465157","volume":"9","author":"AC Gomes","year":"2018","unstructured":"Gomes AC, Hoffmann C, Mota JF. The human gut microbiota: metabolism and perspective in obesity. Gut Microbes. 2018;9(4):308\u201325. https:\/\/doi.org\/10.1080\/19490976.2018.1465157.","journal-title":"Gut Microbes"},{"issue":"4","key":"732_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13679-015-0172-9","volume":"4","author":"FF Anh\u00ea","year":"2015","unstructured":"Anh\u00ea FF, Varin TV, Le Barz M, Desjardins Y, Levy E, Roy D, et al. Gut Microbiota Dysbiosis in Obesity-Linked Metabolic Diseases and Prebiotic Potential of Polyphenol-Rich Extracts. Curr Obes Rep. 2015;4(4):389\u2013400. https:\/\/doi.org\/10.1007\/s13679-015-0172-9.","journal-title":"Curr Obes Rep"},{"key":"732_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.obmed.2026.100694","volume":"61","author":"P Picheswara Rao","year":"2026","unstructured":"Picheswara Rao P. Microbiota\u2013gut\u2013brain axis dysregulation in obesity: neuroimmune-endocrine mechanisms and precision therapeutic targets. Obes Med. 2026;61:100694. https:\/\/doi.org\/10.1016\/j.obmed.2026.100694.","journal-title":"Obes Med"},{"key":"732_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/nu13061902","author":"P D\u00e9chelotte","year":"2021","unstructured":"D\u00e9chelotte P, Breton J, Trotin-Picolo C, Grube B, Erlenbeck C, Bothe G, et al. The probiotic strain H. alvei HA4597(\u00ae) improves weight loss in overweight subjects under moderate hypocaloric diet: a proof-of-concept, multicenter randomized, double-blind placebo-controlled study. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13061902.","journal-title":"Nutrients"},{"issue":"10","key":"732_CR129","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","volume":"34","author":"CK Wong","year":"2022","unstructured":"Wong CK, Yusta B, Koehler JA, Baggio LL, McLean BA, Matthews D, et al. Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation. Cell Metabol. 2022;34(10):1514\u2013e15311517. https:\/\/doi.org\/10.1016\/j.cmet.2022.08.003.","journal-title":"Cell Metabol"},{"issue":"22","key":"732_CR130","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1021\/acs.jmedchem.0c00944","volume":"63","author":"K Futatsugi","year":"2020","unstructured":"Futatsugi K, Smith AC, Tu M, Raymer B, Ahn K, Coffey SB, et al. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. J Med Chem. 2020;63(22):13546\u201360. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00944.","journal-title":"J Med Chem"},{"issue":"1","key":"732_CR131","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2023.02.010","volume":"79","author":"RN Helsley","year":"2023","unstructured":"Helsley RN, Park SH, Vekaria HJ, Sullivan PG, Conroy LR, Sun RC, et al. Ketohexokinase-C regulates global protein acetylation to decrease carnitine palmitoyltransferase 1a-mediated fatty acid oxidation. J Hepatol. 2023;79(1):25\u201342. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.010.","journal-title":"J Hepatol"},{"issue":"1","key":"732_CR132","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hep.31000","volume":"72","author":"MM Syed-Abdul","year":"2020","unstructured":"Syed-Abdul MM, Parks EJ, Gaballah AH, Bingham K, Hammoud GM, Kemble G, et al. Fatty acid synthase inhibitor TVB-2640 reduces hepatic de novo lipogenesis in males with metabolic abnormalities. Hepatology. 2020;72(1):103\u201318. https:\/\/doi.org\/10.1002\/hep.31000.","journal-title":"Hepatology"},{"issue":"9","key":"732_CR133","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/s2468-1253(20)30186-2","volume":"5","author":"R Loomba","year":"2020","unstructured":"Loomba R, Morgan E, Watts L, Xia S, Hannan LA, Geary RS, et al. Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. lancet Gastroenterol Hepatol. 2020;5(9):829\u201338. https:\/\/doi.org\/10.1016\/s2468-1253(20)30186-2.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"10505","key":"732_CR134","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/s0140-6736(25)00979-1","volume":"406","author":"R Loomba","year":"2025","unstructured":"Loomba R, Morgan E, Yousefi K, Li D, Geary R, Bhanot S, et al. Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet (London England). 2025;406(10505):821\u201331. https:\/\/doi.org\/10.1016\/s0140-6736(25)00979-1.","journal-title":"Lancet (London England)"},{"key":"732_CR135","doi-asserted-by":"publisher","first-page":"154299","DOI":"10.1016\/j.metabol.2020.154299","volume":"111s","author":"B Dewidar","year":"2020","unstructured":"Dewidar B, Kahl S, Pafili K, Roden M. Metabolic liver disease in diabetes - from mechanisms to clinical trials. Metab Clin Exp. 2020;111s:154299. https:\/\/doi.org\/10.1016\/j.metabol.2020.154299.","journal-title":"Metab Clin Exp"},{"issue":"12","key":"732_CR136","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","volume":"16","author":"EJ Lawitz","year":"2018","unstructured":"Lawitz EJ, Coste A, Poordad F, Alkhouri N, Loo N, McColgan BJ, et al. Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2018;16(12):1983\u20131991.e1983. https:\/\/doi.org\/10.1016\/j.cgh.2018.04.042.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"732_CR137","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.cgh.2014.04.038","volume":"12","author":"R Safadi","year":"2014","unstructured":"Safadi R, Konikoff FM, Mahamid M, Zelber-Sagi S, Halpern M, Gilat T, et al. The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12(12):2085\u20132091.e2081. https:\/\/doi.org\/10.1016\/j.cgh.2014.04.038.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"732_CR138","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/hep.30674","volume":"70","author":"VH Ajmera","year":"2019","unstructured":"Ajmera VH, Cachay E, Ramers C, Vodkin I, Bassirian S, Singh S, et al. MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial). Hepatology (Baltimore MD). 2019;70(5):1531\u201345. https:\/\/doi.org\/10.1002\/hep.30674.","journal-title":"Hepatology (Baltimore MD)"},{"key":"732_CR139","doi-asserted-by":"publisher","first-page":"101178","DOI":"10.1016\/j.molmet.2021.101178","volume":"46","author":"L Goedeke","year":"2021","unstructured":"Goedeke L, Shulman GI. Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH. Mol Metab. 2021;46:101178. https:\/\/doi.org\/10.1016\/j.molmet.2021.101178.","journal-title":"Mol Metab"},{"issue":"8","key":"732_CR140","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/thy.2020.0071","volume":"30","author":"R Zucchi","year":"2020","unstructured":"Zucchi R. Thyroid hormone analogues: an update. Thyroid. 2020;30(8):1099\u2013105. https:\/\/doi.org\/10.1089\/thy.2020.0071.","journal-title":"Thyroid"},{"issue":"1","key":"732_CR141","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/oby.22344","volume":"27","author":"ED Charles","year":"2019","unstructured":"Charles ED, Neuschwander-Tetri BA, Pablo Frias J, Kundu S, Luo Y, Tirucherai GS, et al. Pegbelfermin (BMS-986036), PEGylated FGF21, in patients with obesity and type 2 diabetes: results from a randomized phase 2 study. Obesity Silver Spring. 2019;27(1):41\u20139. https:\/\/doi.org\/10.1002\/oby.22344.","journal-title":"Obesity Silver Spring"},{"issue":"2","key":"732_CR142","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ajcn\/nqy132","volume":"108","author":"OL Dollerup","year":"2018","unstructured":"Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, et al. A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. Am J Clin Nutr. 2018;108(2):343\u201353. https:\/\/doi.org\/10.1093\/ajcn\/nqy132.","journal-title":"Am J Clin Nutr"},{"issue":"6547","key":"732_CR143","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224\u20139. https:\/\/doi.org\/10.1126\/science.abe9985.","journal-title":"Science"},{"issue":"16","key":"732_CR144","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.7150\/thno.45003","volume":"10","author":"Q Yang","year":"2020","unstructured":"Yang Q, Hu J, Yang Y, Chen Z, Feng J, Zhu Z, et al. Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes. Theranostics. 2020;10(16):7465\u201379. https:\/\/doi.org\/10.7150\/thno.45003.","journal-title":"Theranostics"},{"key":"732_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112697","volume":"148","author":"L Fan","year":"2022","unstructured":"Fan L, Niu H, Zhao L, Yao R, He X, Lu B, et al. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR\/S6K1\/SREBP-1c signaling pathway. Biomed Pharmacother. 2022;148:112697. https:\/\/doi.org\/10.1016\/j.biopha.2022.112697.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"732_CR146","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology \u2014 divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710\u201330. https:\/\/doi.org\/10.1038\/nrendo.2017.91.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"732_CR147","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/bj20120060","volume":"448","author":"Y Angin","year":"2012","unstructured":"Angin Y, Steinbusch LK, Simons PJ, Greulich S, Hoebers NT, Douma K, et al. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes. Biochem J. 2012;448(1):43\u201353. https:\/\/doi.org\/10.1042\/bj20120060.","journal-title":"Biochem J"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00732-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-026-00732-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-026-00732-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:38:10Z","timestamp":1782700690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-026-00732-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":147,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s13679-026-00732-5","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}